| __timestamp | Bausch Health Companies Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2026300000 | 72471000 |
| Thursday, January 1, 2015 | 2682700000 | 89204000 |
| Friday, January 1, 2016 | 2810000000 | 106010000 |
| Sunday, January 1, 2017 | 2582000000 | 137905000 |
| Monday, January 1, 2018 | 2473000000 | 159888000 |
| Tuesday, January 1, 2019 | 2554000000 | 158425000 |
| Wednesday, January 1, 2020 | 2367000000 | 200677000 |
| Friday, January 1, 2021 | 2624000000 | 304759000 |
| Saturday, January 1, 2022 | 2625000000 | 377221000 |
| Sunday, January 1, 2023 | 2917000000 | 336361000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, Bausch Health Companies Inc. and Supernus Pharmaceuticals, Inc. have taken different paths in optimizing these costs. From 2014 to 2023, Bausch Health consistently reported higher SG&A expenses, peaking at nearly $2.9 billion in 2023. In contrast, Supernus Pharmaceuticals maintained a leaner approach, with expenses reaching approximately $336 million in the same year.
Despite Bausch Health's larger scale, Supernus Pharmaceuticals has shown a remarkable ability to control costs, with their SG&A expenses growing by about 364% over the period, compared to Bausch's 44% increase. This strategic cost management could be a key factor in Supernus's competitive edge. As the industry evolves, the ability to optimize SG&A costs will remain a critical determinant of success.
Who Optimizes SG&A Costs Better? AbbVie Inc. or Supernus Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Bristol-Myers Squibb Company vs Supernus Pharmaceuticals, Inc.
Comparing SG&A Expenses: United Therapeutics Corporation vs Bausch Health Companies Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Insmed Incorporated or Supernus Pharmaceuticals, Inc.
Comparing SG&A Expenses: Jazz Pharmaceuticals plc vs Bausch Health Companies Inc. Trends and Insights
Ionis Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
CRISPR Therapeutics AG and Bausch Health Companies Inc.: SG&A Spending Patterns Compared
Bausch Health Companies Inc. vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Bausch Health Companies Inc. and Xencor, Inc.
Bausch Health Companies Inc. or Evotec SE: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Supernus Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Supernus Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.